| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 88.25▼ | 88.30▼ | 87.87▲ | 83.47▲ | 76.61▲ |
| MA10 | 88.37▼ | 87.93▲ | 87.77▲ | 80.87▲ | 71.23▲ |
| MA20 | 88.02▼ | 88.01▼ | 85.02▲ | 76.55▲ | 66.63▲ |
| MA50 | 88.14▼ | 83.51▲ | 81.37▲ | 70.76▲ | 64.57▲ |
| MA100 | 85.55▲ | 81.04▲ | 78.44▲ | 66.49▲ | 55.65▲ |
| MA200 | 82.42▲ | 77.49▲ | 74.05▲ | 63.47▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.022▼ | -0.274▼ | 0.074▲ | 1.048▲ | 2.067▲ |
| RSI | 48.750▼ | 58.007▲ | 67.890▲ | 78.158▲ | 75.237▲ |
| STOCH | 47.715 | 50.445 | 37.226 | 90.932▲ | 82.279▲ |
| WILL %R | -43.333 | -77.212▼ | -41.302 | -16.893▲ | -10.792▲ |
| CCI | -30.001 | -29.359 | 41.392 | 213.058▲ | 234.875▲ |
|
Thursday, October 16, 2025 05:12 AM
Belite Bio Inc (NASDAQ: BLTE) (“Belite” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have ...
|
|
Wednesday, October 15, 2025 05:13 AM
NMPA’s response is based on the Phase 3 DRAGON interim analysis resultsTopline final data expected in Q4 2025SAN DIEGO, Oct. 15, 2025 (GLOBE ...
|
|
Wednesday, October 15, 2025 04:02 AM
Having China NMPA agreed to review the NDA based on interim Phase 3 data is a remarkable milestone for Belite Bio and the Stargardt community,” said Dr. Tom Lin, Chairman and CEO of Belite Bio. “This ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/10/25 | 90.15 | 91.46 | 86.66 | 87.97 | 96,227 |
| 16/10/25 | 81.01 | 90.00 | 81.01 | 89.07 | 143,584 |
| 15/10/25 | 80.00 | 81.505 | 79.05 | 81.26 | 74,700 |
| 14/10/25 | 79.70 | 80.04 | 78.71 | 79.26 | 32,826 |
| 13/10/25 | 80.00 | 80.185 | 78.81 | 79.77 | 29,751 |
| 10/10/25 | 78.47 | 79.41 | 77.64 | 79.28 | 38,190 |
| 09/10/25 | 78.13 | 80.00 | 77.125 | 78.50 | 73,500 |
| 08/10/25 | 76.50 | 79.9999 | 76.50 | 78.06 | 40,999 |
| 07/10/25 | 78.75 | 79.95 | 76.2332 | 77.40 | 126,539 |
| 06/10/25 | 75.948 | 78.50 | 75.948 | 78.10 | 96,020 |
|
|
||||
|
|
||||
|
|